Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2024?

167 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2024. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 81,357,406
Total 13F value: $209,091,543
Share change: -1,678,380
Put/Call ratio: 35%
SEC-reported price per share: $2.57
Number of holders: 167
Value change: -$16,845,100
Number of buys: 86
Number of sells: 80
Shares outstanding: 104,661,494

Security key

761330109

Report period

Q2 2024

Institutions

167

Top holders

RVNC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Revance Therapeutics, Inc. SEC filings Revance Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 761330109

Newer quarter: Q3 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Capital World Investors

Disclosed value leader

Capital World Investors

Comparable rows

0/15

Latest evidence

31 Mar 2024

13F Highest disclosed value: $68,612,032 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Capital World Investors has the largest disclosed position value at $68.61M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital World Investors's linked filing trail.

Disclosed position value Top 5

Capital World Investors $68.61M

BlackRock Finance, Inc. $35.98M

FRANKLIN TEMPLETON INC $30.91M

VANGUARD GROUP INC $26.56M

Palo Alto Investors LP $25.82M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital World Investors	13F Company 13F	— denominator unverified	$68,612,032 13,945,535 shares	—	31 Mar 2024
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$35,977,397 7,312,479 shares	—	31 Mar 2024
FRANKLIN TEMPLETON INC	13F Company 13F	— denominator unverified	$30,914,364 6,283,407 shares	—	31 Mar 2024
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$26,560,157 5,398,406 shares	—	31 Mar 2024
Palo Alto Investors LP	13F Company 13F	— denominator unverified	$25,820,180 5,248,004 shares	—	31 Mar 2024
Polar Capital Holdings Plc	13F Company 13F	— denominator unverified	$19,113,309 3,884,819 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

167

81,357,406

Rows available

167

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q3 2025 Across Filers

Q3 2025 holders

Q2 2024 holders

167

Holder diff

166

Investor	Q3 2025 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q3 2025 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend